Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Cervical Cancer Screening Market in Aging Female Population

Renub Research
Posted on: 04 Aug 17
Global Cervical Cancer Screening Market in Aging Female Population

Download full Report:


One of the most widespread cancer diseases in Women globally is Cervical Cancer. Cervical cancer is a disease with the long hidden era, early on recognition and care of precancerous lesions were extremely effective in women who often take screening tests. Mostly in many incidences, the disease is recognized as Human Papilloma Virus (HPV) infection. But in many developed nations, the death rate because of cervical cancer screening has fallen down. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020. 

How Cervical Cancer Occurs & their Symptoms

In cervical cancer malignant tumor is in the lower most part of the uterus (womb). Symptoms consist of bleeding in between periods and after sexual intercourse. Pain may also occur in lower back pain or lower abdominal and foul smelling white discharge. There are many cases when there are no symptoms found.

The Cervical cancer can be prevented by HPV vaccine as well as PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Ages and their occurrence can be distinguished in following manners.

Ages        Occurrences
0 to2         Never    
3 to 5        Never
6 to 13      Never
14 to 18    Very Rare
19 to 40    Rare
41 to 60    Rare

The Cervical cancer test includes Human Papilloma Virus (HPV) vaccine and PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Human Papilloma Virus (HPV) test occurs when the symptoms of HPV mainly causes infection in mouth, hand, genitals and fingers. Globally focus on HPV testing because of the rising awareness about and the link between HPV and Cervical cancer. PAP smear screening, been widely used as primary screening test for cervical cancer treatments. Changing the center on HPV testing as the primary screening test because of lower test sensitivity, higher negative results etc.

Cervical Cancer Test Market & Market Share: Overview

In Cervical cancer market 50 percent of the market share is jointly captured by the United States and Japan. In market research report, published by Renub Research found that Japan market will decline in future. The United Kingdom and France lead the cervical cancer market in Europe. Nations like India, China and Indonesia captures most of the cervical cancer test population.

Challenges in Cervical Cancer Globally

Globally challenges of cervical cancer are the scarcity of gynecologists and pathologists, lack of awareness of diseases, lack of government facilities and policies in low income nations.

The Report Studies the Global Cervical Cancer Screening Market on the basis of:
1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia

Cervical Cancer Test Market

• Pap Smear Test Market & Forecast
• HPV DNA Test Market & Forecast
• VIA Test Market & Forecast


Contact Us

Rajat Gupta

Sr. Marketing Manager


Phone: +1-678-302-0700


For more information:

Editor's Details

Rajat Gupta
Renub Research

Last updated on: 04/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.